Evidence map›Paper›PMID 30385714›Full record

ArticleJCI insight2018

A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis.

Ryoji Ito, Shuichiro Maruoka, Kaori Soda, Ikumi Katano, Kenji Kawai, Mika Yagoto, Asami Hanazawa, Takeshi Takahashi, Tomoyuki Ogura, Motohito Goto and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. LKB1 deficiency upregulates RELM-α to drive airway goblet cell metaplasia.Cellular and molecular life sciences : CMLS · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Recent Advances in Allergy Research Using Humanized Mice.International journal of molecular sciences · 2019
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Ryoji ItoCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Shuichiro MaruokaDivision of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
Kaori SodaDivision of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
Ikumi KatanoCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Kenji KawaiCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Mika YagotoCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Asami HanazawaCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Takeshi TakahashiCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Tomoyuki OguraCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Motohito GotoCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Riichi TakahashiCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Shota ToyoshimaAllergy and Immunology Research Project Team, Research Institute of Medical Science, Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, Japan.
Yoshimichi OkayamaAllergy and Immunology Research Project Team, Research Institute of Medical Science, Center for Institutional Research and Medical Education, Nihon University School of Medicine, Tokyo, Japan.
Kenji IzuharaDivision of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
Yasuhiro GonDivision of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
Shu HashimotoDivision of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan.
Mamoru ItoCentral Institute for Experimental Animals (CIEA), Kanagawa, Japan.
Satoshi NunomuraDivision of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
Central Institute for Experimental Animals · JPNihon University · JPSaga Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is one of the most common immunological diseases and is characterized by airway hyperresponsiveness (AHR), mucus overproduction, and airway eosinophilia. Although mouse models have provided insight into the mechanisms by which type-2 cytokines induce asthmatic airway inflammation, differences between the rodent and human immune systems hamper efforts to improve understanding of human allergic diseases. In this study, we aim to establish a preclinical animal model of asthmatic airway inflammation using humanized IL-3/GM-CSF or IL-3/GM-CSF/IL-5 Tg NOD/Shi-scid-IL2rγnull (NOG) mice and investigate the roles of human type-2 immune responses in the asthmatic mice. Several important characteristics of asthma - such as AHR, goblet cell hyperplasia, T cell infiltration, IL-13 production, and periostin secretion - were induced in IL-3/GM-CSF Tg mice by intratracheally administered human IL-33. In addition to these characteristics, human eosinophilic inflammation was observed in IL-3/GM-CSF/IL-5 Tg mice. The asthmatic mechanisms of the humanized mice were driven by activation of human Th2 and mast cells by IL-33 stimulation. Furthermore, treatment of the humanized mice with an anti-human IL-13 antibody significantly suppressed these characteristics. Therefore, the humanized mice may enhance our understanding of the pathophysiology of allergic disorders and facilitate the preclinical development of new therapeutics for IL-33-mediated type-2 inflammation in asthma.

Indexed as

AnimalsAsthmaCytokinesDisease Models, AnimalEosinophilsGoblet CellsGranulocyte-Macrophage Colony-Stimulating FactorHumansInflammationInterleukin-13Interleukin-33MiceMice, Inbred NODRespiratory HypersensitivityCytokinesGranulocyte-Macrophage Colony-Stimulating FactorIL13 protein, humanIL33 protein, humanInterleukin-13Interleukin-33AllergyAsthmaImmunologyInflammationMouse models

Identifiers

PMID30385714
PMCPMC6238753
OpenAlexW2896619981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.